Source: MarketScreener

Flexion: Pacira BioSciences : Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management - Form 8-K

(marketscreener.com) Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management -- Adds highly complementary ZILRETTA® to Pacira commercial offering -- -- Combined portfolio offers end-to-end non-opioid solutions along the pain pathway -- ...https://www.marketscreener.com/quote/stock/PACIRA-BIOSCIENCES-INC-7299436/news/Pacira-BioSciences-Completes-Acquisition-of-Flexion-Therapeutics-and-Strengthens-Leadership-Positi-37083078/?utm_medium=RSS&utm_content=20211119

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
250-500
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more